Cellink Financial Statements From 2010 to 2024
| 49Z Stock | EUR 3.60 0.53 17.26% |
Check Cellink AB financial statements over time to gain insight into future company performance. You can evaluate financial statements to find patterns among Cellink AB's main balance sheet or income statement drivers, such as , as well as many indicators such as . Cellink financial statements analysis is a perfect complement when working with Cellink AB Valuation or Volatility modules.
Cellink |
Cellink AB Company Shares Outstanding Analysis
Cellink AB's Outstanding Shares are shares of common stock of a public company that were purchased by investors after they were authorized and issued by the company to the public. Outstanding Shares are typically reported on fully diluted basis, including exotic instruments such as options, or convertibles bonds.
Current Cellink AB Shares Outstanding | 69.07 M |
Most of Cellink AB's fundamental indicators, such as Shares Outstanding, are part of a valuation analysis module that helps investors searching for stocks that are currently trading at higher or lower prices than their real value. If the real value is higher than the market price, Cellink AB is considered to be undervalued, and we provide a buy recommendation. Otherwise, we render a sell signal.
Outstanding shares that are stated on company Balance Sheet are used when calculating many important valuation and performance indicators including Return on Equity, Market Cap, EPS and many others.
| Competition |
Based on the latest financial disclosure, Cellink AB has 69.07 M of shares currently outstending. This is 61.74% lower than that of the Healthcare sector and 60.52% lower than that of the Medical Devices industry. The shares outstanding for all Germany stocks is 87.92% higher than that of the company.
Cellink AB Fundamental Drivers Relationships
Comparative valuation techniques use various fundamental indicators to help in determining Cellink AB's current stock value. Our valuation model uses many indicators to compare Cellink AB value to that of its competitors to determine the firm's financial worth. You can analyze the relationship between different fundamental ratios across Cellink AB competition to find correlations between indicators driving Cellink AB's intrinsic value. More Info.Cellink AB is number one stock in return on equity category among its peers. It also is number one stock in return on asset category among its peers . The reason why the comparable model can be used in almost all circumstances is due to the vast number of multiples that can be utilized, such as the price-to-earnings (P/E), price-to-book (P/B), price-to-sales (P/S), price-to-cash flow (P/CF), and many others. The P/E ratio is the most commonly used of these ratios because it focuses on the Cellink AB's earnings, one of the primary drivers of an investment's value.About Cellink AB Financial Statements
Cellink AB stakeholders use historical fundamental indicators, such as Cellink AB's revenue or net income, to determine how well the company is positioned to perform in the future. Although Cellink AB investors may analyze each financial statement separately, they are all interrelated. For example, changes in Cellink AB's assets and liabilities are reflected in the revenues and expenses on Cellink AB's income statement, which ultimately affect the company's gains or losses. Understanding these patterns can help in making the right long-term investment decisions in Cellink AB. Please read more on our technical analysis and fundamental analysis pages.
Cellink AB , a bio convergence company, designs and develops bioprinting, liquid handling, single-cell analysis, and live-cell imaging technologies in North America, Europe, Asia, and internationally. Cellink AB was founded in 2016 and is headquartered in Gothenburg, Sweden. CELLINK AB is traded on Frankfurt Stock Exchange in Germany.
Currently Active Assets on Macroaxis
Other Information on Investing in Cellink Stock
Cellink AB financial ratios help investors to determine whether Cellink Stock is cheap or expensive when compared to a particular measure, such as profits or enterprise value. In other words, they help investors to determine the cost of investment in Cellink with respect to the benefits of owning Cellink AB security.